ALBANY, New York, January 31, 2012 /PRNewswire/ --
AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year financial results before the opening of the market on Tuesday, February 7, 2012. Following the release of its results, the company will host a conference call and simultaneous webcast at 10 a.m. ET.
The conference call can be accessed by dialing 800-341-3130 (domestic calls) or +1-913-312-1393 (international calls) at 9:45 a.m. ET and entering passcode 6376884. The webcast will be available live via the Internet and can be accessed on the company's website at http://www.amriglobal.com. Replays of the webcast can also be accessed for up to 90 days after the call via the investor area of the company's website at http://www.amriglobal.com/investor_relations/.
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization with more than twenty years experience providing customers fully integrated drug discovery, development, and manufacturing services. AMRI supplies a broad range of services and technologies that support the discovery and development of pharmaceutical products and the manufacturing of API and drug product for existing and experimental new drugs. With locations in the United States, Europe, and Asia, AMRI maintains geographic proximity and flexible cost models. AMRI has also historically leveraged its drug-discovery expertise to execute on several internal drug discovery programs, which have progressed to the development candidate stage and in some cases into Phase I clinical development. AMRI has successfully partnered certain programs and is actively seeking to out-license its remaining programs to strategic partners for further development.